Xin-Yu Liu

Xin-Yu Liu

Auto-generated profile, based on publicly available information

Xin-Yu Liu

Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LXLuang Xu
Luang Xu
XLXinyu Liu
Xinyu Liu
NSNa Sheng
Na Sheng
KOKyaw Soe Oo
Kyaw Soe Oo
JLJunxin Liang
Junxin Liang
XFXin-Yuan Fu
Xin-Yuan Fu
Chemical RNA modifications are central features of epitranscriptomics, highlighted by the discovery of modified ribonucleosides in mRNA and exemplified by the critical roles of RNA modifications in normal physiology and disease. Despite a resurgent interest in these modifications, the biochemistry of 3-methylcytidine (m3C) formation in mammalian RNAs is still poorly understood. However, the recent discovery of trm141 as the second gene responsible for m3C presence in RNA in fission yeast raises the possibility that multiple enzymes are involved in m3C formation in mammals as well. Here, we report the discovery and characterization of three distinct m3C-contributing enzymes in mice and humans. We found that methyltransferase-like (METTL) 2 and 6 contribute m3C in specific tRNAs and that METTL8 only contributes m3C to mRNA. MS analysis revealed that there is an ∼30–40% and ∼10–15% reduction, respectively, in METTL2 and -6 null-mutant cells, of m3C in total tRNA, and primer extension analysis located METTL2-modified m3C at position 32 of tRNAThr isoacceptors and tRNAArg(CCU). We also noted that METTL6 interacts with seryl-tRNA synthetase in an RNA-dependent manner, suggesting a role for METTL6 in modifying serine tRNA isoacceptors. METTL8, however, modified only mRNA, as determined by biochemical and genetic analyses in Mettl8 null-mutant mice and two human METTL8 mutant cell lines. Our findings provide the first evidence of the existence of m3C modification in mRNA, and the discovery of METTL8 as an mRNA m3C writer enzyme opens the door to future studies of other m3C epitranscriptomic reader and eraser functions.

3 September 2012 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
LDLiang Dai
Liang Dai
CTChan Aye Thu
Chan Aye Thu
XLXin‐Yu Liu
Xin‐Yu Liu
JXJiajia Xi
Jiajia Xi
PCPeter C. F. Cheung
Peter C. F. Cheung

24 February 2011 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
HSHilary Smith
Hilary Smith
XLXin-Yu Liu
Xin-Yu Liu
LDLiang Dai
Liang Dai
EGEddy T. H. Goh
Eddy T. H. Goh
ACAye-Thu Chan
Aye-Thu Chan
PCPeter C. F. Cheung
Peter C. F. Cheung
Mammalian Pellino isoforms are phosphorylated by IRAK (interleukin receptor associated kinase) 1/IRAK4 in vitro, converting them into active E3 ubiquitin ligases. In the present paper we report a striking enhancement in both transcription of the gene encoding Pellino 1 and Pellino 1 protein expression when murine BMDMs (bone-marrow-derived macrophages) are stimulated with LPS (lipopolysaccharide) or poly(I:C). This induction occurs via a TRIF [TIR (Toll/interleukin-1 receptor)-domain-containing adaptor-inducing interferon-β]-dependent IRAK-independent pathway and is prevented by inhibition of the IKK [IκB (inhibitor of nuclear factor κB) kinase]-related protein kinases, TBK1 {TANK [TRAF (tumour-necrosis-factor-receptor-associated factor)-associated nuclear factor κB activator]-binding kinase 1} and IKKϵ. Pellino 1 is not induced in IRF3 (interferon regulatory factor 3)−/− BMDMs, and its induction is only reduced slightly in type 1 interferon receptor−/− BMDMs, identifying Pellino 1 as a new IRF3-dependent gene. We also identify Pellino 1 in a two-hybrid screen using IKKϵ as bait, and show that IKKϵ/TBK1 activate Pellino 1 in vitro by phosphorylating Ser76, Thr288 and Ser293. Moreover, we show that the E3 ligase activity of endogenous Pellino 1 is activated in LPS- or poly(I:C)-stimulated macrophages. This occurs more rapidly than the increase in Pellino 1 mRNA and protein expression, is prevented by the inhibition of IKKϵ/TBK1 and is reversed by phosphatase treatment. Thus IKKϵ/TBK1 mediate the activation of Pellino 1's E3 ligase activity, as well as inducing the transcription of its gene and protein expression in response to TLR3 and TLR4 agonists.

1 July 2018 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
YHYing-Bin Hu
Ying-Bin Hu
XLXin-Yu Liu
Xin-Yu Liu
WZWei Zhan
Wei Zhan
Introduction: Nonalcoholic steatohepatitis (NASH) is largely driven by the dysregulation of liver metabolism and inflammation. Bile acids and their receptor Farnesoid X receptor (FXR) play a critical role in the disease development. Here, we investigated whether INT-767, the newly-identified dual FXR/TGR5 agonist, can protect rat from liver injury during NASH. Materials and methods: NASH model was established by feeding the male SD rats with high-fat diet for 16 weeks. INT-767 was given by gavage to NASH rats from week 13 to week 16. At the end of 16 weeks, liver and serum were harvested, and bile acids, glucose and lipid metabolism, liver injury and histological features were evaluated. Results: INT-767 treatment significantly alleviates high-fat caused liver damage characterized with lipid accumulation and hepatic infiltration of immune cells. INT-767 robustly restores the lipid, glucose metabolism to normal level, attenuates insulin resistance through upregulating FXR level and reverting the dysregulation of its target genes in liver metabolism. Molecularly INT-767 also attenuates the pro-inflammatory response by suppression of TNF-α and NF-κB signaling pathway. Conclusion: INT-767 may be an attractive candidate for a potential novel strategy on the treatment of NASH.

3 August 2018 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
JXJin‐Fen Xiao
Jin‐Fen Xiao
QSQiao‐Yang Sun
Qiao‐Yang Sun
LDLing‐Wen Ding
Ling‐Wen Ding
WCWenwen Chien
Wenwen Chien
XLXin‐Yu Liu
Xin‐Yu Liu
HKH. Phillip Koeffler
H. Phillip Koeffler

19 November 2008 in FEBS Letters
Verified
Journal Article
Closed access
XLXin Yu Liu
Xin Yu Liu
CSCheah Chen Seh
Cheah Chen Seh
PCPeter C.F. Cheung
Peter C.F. Cheung